JAK2 and neoplasm: Whole exome analysis of the resistant tumor clones identified loss-of-function mutations in the genes encoding interferon-receptor-associated Janus kinase 1 (JAK1) or Janus kinase 2 (JAK2), which leads to insensitivity to INFα, β and γ [138,139].